Acetadote is used to treat poisoning by acetaminophen, an ingredient in pain relief and fever-reducing products. Having received US Food and Drug Administration (FDA) approval for the new formulation in January Cumberland is now phasing out the earlier product.
"This launch marks an important milestone in our strategy to support our products by improving upon existing formulations and expanding into new patient populations", said AJ Kazimi, CEO of Cumberland.
Acetadote shipped from now on will be free of ethylene diamine tetracetic acid (EDTA) or any other stabilization or chelating agents.